13:30-13:50 | Keynote |
A critical role for glassy states biomolecular condensates in nanoscale regulation of biology |
|
||||
13:50-14:10 | Keynote |
NPY Nanosystems for Boundarics in Tumor |
|
||||
14:10-14:30 | Keynote |
A Discovery Framework for Nanoparticle Shape-Based Adjuvants |
|
||||
14:30-14:45 | Invited |
Targeted responsive nanoparticles degrade BRD4 to reverse glioma resistance |
|
||||
14:45-15:00 | Invited |
Prodrug-Based Nanotheranostic Platform for Cancer Radiosensitization |
|
||||
15:00-15:10 | Oral Report |
Biomimetic nanomedicines with glycan modification for the enhanced treatment of pathogenic infections |
|
||||
15:10-15:20 | Oral Report |
Submolecular-level dynamic engineering of ligand nanostructure for macrophage immunoregulation |
|
||||
15:20-15:30 | Oral Report |
Polymer-coated iron oxide-embedded lipid nanoparticles (PcIOeLNPs) for mRNA delivery and MRI identified accumulation |
|
||||
15:30-15:45 | Other |
Coffee Break |
15:45-16:05 | Keynote |
RNA Delivery for Treating Brain Disorders |
|
||||
16:05-16:25 | Keynote |
Transformative nanomedicine: from bench to clinic |
|
||||
16:25-16:45 | Invited |
Application of Nanocarrier Surface Modification Strategies in the Development of Innovative Pharmaceutical Formulations |
|
||||
16:45-17:00 | Invited |
Engineering modification and regulation of the cell surface in vivo |
|
||||
17:00-17:15 | Invited |
Polymeric Material for Metal Element Delivery |
|
||||
17:15-17:25 | Oral Report |
Construction and Clinical Transformation of Universal Cancer Vaccines |
|
||||
17:25-17:35 | Oral Report |
Bioactive nanomaterials for cancer therapy, diabetes regulation and mRNA delivery |
|
||||
17:35-17:45 | Oral Report |
Wireless Magnetoelectric Nanotransducers Enable Bimodal Cell Growth and Enhanced Intranasal Delivery |
|